The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1. (Q42163084)
Jump to navigation
Jump to search
scientific article published on July 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1. |
scientific article published on July 2003 |
Statements
The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1 (English)
Roberto R Rosato
Jorge A Almenara